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Abstract 
Introduction: Nitric Oxide (NO) is one of the important compounds in the body. Nitric oxide is a factor for 
blood vessel relaxant. In a reasonable amount of NO compounds also controlling an important physiological role 
in the cell signaling processes and inflammation, however in excessive amounts of NO have a characters as 
reactive oxidative, genotoxic and destrukstif for human cells, therefore necessary to study the profil of NO levels 
in humans.Aim: To determine the mean levels of NO in the Yogyakarta society based on gender, age and body 
mass index (BMI).Methodology: This study used a cross-sectional study design. The respondents are 44 people 
consisting of 11 male and 33 female who live in Yogyakarta. A total of 44 respondents who had appropriate the 
criteria and agree with informed consent then examined the levels of NO plasma using ELISA method. Results 
of the study will be presented in the descriptive and statistical analysis on the relationship of the levels of NO 
with gender, age and BMI at 95% confidence level.Results and discussion: From this research, the results 
showed mean levels of NO is 17.87±7.80 µmol/L. The results of data analysis by the gender showed mean levels 
of NO in male respondents is 21.58±8.42 µmol/L and 16.63±7.31 µmol/L in female respondents. The mean 
levels of NO in male respondents was higher than female. However, there is no significant correlation between 
mean levels of NO in the male respondents and female based on statistical analysis of independent sample T-test 
with p= 0.102 (p>0.05). The mean levels of NO respondents with aged <25 years is lower than aged >25 years. 
Respondents were aged <25 years had mean levels of NO is 17.18±8.00 µmol/L while aged >25 years is 
21.5±5.86 µmol/L. However, based on statistical analysis with independent sample t-test showed p=0.181 
(p>0.05), there is no significant correlation between the mean NO levels aged <25 years with >25 years. The test 
results analysis with independent sample t-test showed no significant correlation between the levels of NO in the 
non-obese and obese respondents with p=0.060 (p>0.05). Based on the results we know the mean NO levels in 
non-obese respondents is 16.55±8.09 µmol/L, where the obese respondents have mean NO levels is 21.00±6.27 
µmol/L. From the results of these studies showed the mean levels of NO respondents with obesity is higher than 
respondents who are non-obese.Conclusions: The mean NO levels of this research in Yogyakarta society is 
17.87±7.80 µmol/L. Based on the gender, the mean levels of NO mile is 21.58±8.42 µmol/L and 16.63±7.31 
µmol/L for female. Based on the age, the mean levels of NO with aged <25 years is 17.18±8.00 µmol/L and >25 
years is 21.5 ±5.86 µmol/L. Based on the BMI, the mean levels of NO with non-obese is 16.55±8.09 µmol/L and 
obese is 21.00±6.27 µmol/L. 
Keywords: Profile, Levels, Nitric oxide (NO) 
 
1.  INTRODUCTION 
Nitric oxide (NO) is a free radical synthesized by an enzyme Nitric Oxide Synthase (NOS) through a complex 
reaction. Nitrite Oxide is natural gas in the body was released by endothelial cells and blood vessel dilator 
substance acts as a short life (Purwadinati et al., 2015). The half-life of NO in the blood vessel is very short 
(about 3-4 seconds), the examination of NO directly is not easy to do, so the examination with indirect methode 
by using the Griess reaction (Widiastuti, 2010). 
In humans, NO is used for several functions intercellular and intracellular signals, such as the 
transmission of neuronal signals, cytotoxic against pathogens and tumors, cardiac rhythm coordination, and 
arrangement of cellular respiration activity (JT Groves et al., 2004). Nitric oxide in relation to the blood vessels 
can cause smooth muscle relaxation, there by functioning as a regulator of flow and blood pressure and prevent 
platelet aggregation and adhesion. Nitric oxide also helps transport oxygen by dilating the blood vessel walls, 
thus the transfer of gas to the blood vessel be easy (Idhayu, 2006). 
The benefits of NO on the body has been widely studied, one of the most important is its role in the 
body's immune system. NO cooperate with the lysosomes of macrophages to kill pathogens such as bacteria, 
fungi and viruses. Nitric oxide help to protect the body from bacteria that enter through the digestive tract. 
Normal flora that live in the mouth and throat convert nitrate to nitrite in the diet will be changed to NO when 
exposed to stomach acid. NO this will kill nearly all pathogens ingested with food (Idhayu, 2006). 
Nitric oxide if released around the kidney glomerulus, can lead to an increase glomerulus Filtration 
Rate (GFR). While NO is released by nerve endings in the penis will cause relaxation of the blood vessels so that 
the corpus cavernosa of the penis fills with blood and produce an erection of the penis (Roitt IM, 2001). The 
function of NO in reproduction is not only there, NO released by the sperm acrosome can activate the egg in 
completing phase meiosis II and another phase fertilization. Another benefit of NO on smooth muscle can be 
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seen on the walls of the gastrointestinal tract, NO affects smooth muscle to help peristaltic of the digestive tract. 
Even NO inhibits smooth muscle contractions of the uterine wall is very beneficial for mothers with premature 
babies, so as to maintain the baby to full term (Idhayu, 2006). 
Hypertension is still a health problem in the world with an ever-increasing prevalence (AW Dreisbach, 
2011). Many risk factors can affect of hypertension in humans such as gender, age, family history, smoking etc. 
Obesity can lead to hypertension. Obesity increases the risk of hypertension by 2.6 fold in men and 2.2 fold in 
women (Lilysari O, 2007). Essential hypertension is characterized by endothelial dysfunction and Increased 
vascular tone and resistance. This is the result of imbalance of endothelium-derived contracting and relaxing 
factors. Nitric oxide, the which is produced locally by the endothelium is crucial for maintaining vascular tone. It 
is still unclear whether NO is a marker or a mediator for endothelial dysfunction in hypertension and also 
whether changes in NO levels occur as primary or secondary events (Saha et al., 2013). So, necessary to study 
the profil of NO levels in humans. 
 
2.  METHODE 
This type of research is descriptive analysis with cross sectional study design. This study was conducted in 
Yogyakarta. Examination of blood samples carried out in LPPT UGM. Populations are people living in 
Yogyakarta. Samples are part of a population that is 44 people of Yogyakarta is composed of 11 male and 33 
female who had appropiate the criteria which healthy volunteers were evidenced by a health certificate from the 
hospital authorities, male and female aged 18-60 years and willing to be the subject of (fill informed consent). 
The independent variable in this study were age, gender and body mass index (BMI), while the dependent 
variable yiatu NO levels. The research instrument used in this study ELISA Reader is used to measure the levels 
of NO. Respondents who had appropiate the criteria and agree with informed consent then examined the levels 
of NO plasma using ELISA method. Results of the study will be presented in the form of descriptive and 
statistical analysis on the relationship of the levels of NO to gender, age and BMI at 95% confidence level. 
 
3.  RESULTS AND DISCUSSION 
Research conducted on the people of Yogyakarta aims to determine how the profile of plasma NO levels 
Yogyakarta society. Respondents were used in this study amounted to 44 people consisting of male and female 
as many as 11 people as many as 33 people. Age of respondents in this study ranged from 18-60 years consisting 
of 36 people aged <25 years and 8 people aged >25 years. Characteristics of respondents in this study can be 
showed in Table 1. 
Table 1. Characteristics of Respondents 
 
Nitric Oxide is an important compound in the human body. Many research demonstrate that NO has 
many benefits such as the immune system can kill the bacteria, vascular homeostasis settings so that interference 
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with the synthesis of NO associated with an increased risk of cardiovascular disease (JT Groves et al., 2004). 
Nitric Oxide is a natural gas in the body is released by endothelial cells and blood vessel dilator substance acts as 
a short life with normal levels of 25-45 µmol/L (Purwadinati et al., 2015). 
In a reasonable amount of NO compounds also controlling an important physiological role in the cell 
signaling processes and inflammation, however in excessive amounts of NO have a characters as reactive 
oxidative, genotoxic and destrukstif for human cells (Giordano et al., 2011; Acharya et al., 2010). Excessive NO 
production can improve the activation of the enzyme guanylate cyclase which may cause negative effects, such 
as inactivity of certain enzymes, proteins induced stress and even damage DNA (TM Devlin, 2002). From this 
research, the results showed mean levels of NO is 17.87±7.80 µmol/L. Results of the study the levels of NO in 
Yogyakarta society based on gender can be seen in Table 2. 
Table 2. Distribution of NO levels by Sex and Relationship Sex with levels of NO 
Gender n Mean±SD of NO Minumum NO Maximum NO p  
  Levels (µmol/L) Levels (µmol/L) Levels (µmol/L)   
Male 11 21,58± 8,42 8,04 36,30 
0,102 
 
Female 33 16,63± 7,31 5,64 32,09 
 
  
Results of the study data analysis by gender showed that mean levels of NO in the male respondents 
was higher than women. The mean levels of NO in male respondents is 21.58±8.42 µmol/L with minimum NO 
levels is 8.04 µmol/L and the maximum is 36.30 µmol/L. In the female respondents the mean levels of NO that 
is 16.63±7.31 µmol/L with minimum NO levels is 5.64 µmol/L and a maximum of 32.09 µmol/L. 
Test results analysis with independent sample t-test showed no significant correlation between the mean 
levels of NO in the male respondents and female with p= 0.102. Hypertension is more common in men occurs 
after the age of 31 years, while in women occurs after age 45 (after menopause). In West Java, the prevalence of 
hypertension in males approximately 23.1% and approximately 6.5% in women. At the age of 50-59 years the 
prevalence of hypertension in males approximately 53.8% while the female is about 29% and at the age of 60 
years the prevalence of hypertension approximately 64.5%. Isral et al (2014) demonstrate the levels of NO in 
respondents who had hypertension (26.91±15.40 µmol/L) greater than healthy respondents (25.78±15. µmol/L). 
So, a male can to develop hypertension than female because levels of NO in male is higher than female. 
Table 3. Distribution of NO levels by Age 
Age n Mean±SD of NO Minumum NO Maximum NO p  
(Years)  Levels (µmol/L) Levels (µmol/L) Levels (µmol/L)   
<25 36 17,18± 8,00 5,64 36,30 
0,121
 
>25 8 21,51± 5,86 13,16 30,43 
 
  
Analysis of data the mean levels of NO by age showed that respondents aged <25 years lower than 
aged >25 years. Respondents were aged <25 years had higher levels of NO 17.18±5.64 µmol/L with minimum 
NO levels of 5.64 µmol/L and a maximum is 36.30 µmol/L. Respondents were aged >25 years had mean levels 
of NO is 21.51±5.86 µmol/L with minimum NO levels is 13.16 µmol/L and a maximum is 30.43 µmol/L. The 
test results analysis with independent sample t-test, the mean levels of NO in respondents aged <25 years 
and >25 years showed no significant relationship between the mean levels of NO in respondents aged <25 years 
and >25 years with p = 0.121. 
Age is a risk factor for hypertension that can not be prevented because according to research by the 
increasing age of a person, so the greater the risk of developing hypertension. According to Dede Kusmana of 
the Department of Cardiology, University of Indonesia (2007), that hypertensive patients aged between 20-30 
years, the prevalence is 5-10%, the prevalence of young adults aged between 20-25% and above 50 years of age 
about 60%. According to Saha et al (2013) in the group of respondents with hypertension had higher levels of 
NO were higher (43.77±0.29 µmol/L) compared to the control group or normotensive (38.57±5.02 µmol/L) 
which in hypertensive patients Endothelial damage occurs so that the production of NO increases. So that, the 
increasing age of the higher risk of hypertension that it is influenced by increased levels of NO as a result of 
endothelial damage. 
Table 4. Distribution of NO levels based on BMI and BMI relationship with the levels of NO 
BMI n Mean±SD of NO Minumum NO Maximum NO p  
  Levels (µmol/L) Levels (µmol/L) Levels (µmol/L)   
Non-Obese 31 16,55± 8,09 5,64 36,30 
0,060
 
Obese 13 21,00± 6,27 10,43 32,09 
 
  
Test results analysis with independent sample t-test showed no significant correlation between the mean 
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levels of NO in the non-obese and obese respondents with p=0.060. Based on the results, we known mean levels 
of NO non-obese respondents is 16.55±8.09 µmol/L with minimum levels is 5.64 µmol/L and a maximum levels 
is 36.30 µmol/L, while the respondents with obesity have mean levels of NO is 21.00±6,27 µmol/L with 
minimum levels is 10.43 µmol/L and maximum levels is 32.09 µmol/L. From the results of these studies showed 
the mean levels of NO respondents with higher obesity compared with respondents who are non-obese. 
The results were consistent with studies Choi et al (2001) which states that NO production is increased 
in individuals with obesity both in male and female. Choi et al (2001) also states that the subcutaneous adipose 
tissue is a potential source of NO production. In individuals with obesity increased NO production and this 
increase begins when BMI reaches >25 kg/m2. Choi et al (2001) study shows serum levels of NOx on the subject 
of male and female with a higher excess weight from 4.1 to 4.2 fold compared to subjects that are non-obese. 
Research Beltowski (2002) also showed increased NO production due to increased production of leptin, which is 
directly proportional to the increase in adipose tissue. In individuals with obesity decreased bioavailability of NO 
in circulation caused by impaired synthesis or increased production of NO and Reactive Oxygen Species (ROS). 
This is related to metabolic factors such as leptin resistance and insulin resistance. On obesity also tend to occur 
in a condition called oxidative stress-induced inactivation of NO (Lilysari O, 2007; Sulastri D et al., 2010; 
Fenster CP et al., 2004; Morrison R, 2006; Cahjono H, 2007). 
 
4.  CONCLUSIONS 
The mean NO levels of this research in Yogyakarta society is 17.87±7.80 µmol/L. Based on the gender, the 
mean levels of NO mile is 21.58±8.42 µmol/L and 16.63±7.31 µmol/L for female. Based on the age, the mean 
levels of NO with aged <25 years is 17.18±8.00 µmol/L and >25 years is 21.5 ±5.86 µmol/L. Based on the BMI, 
the mean levels of NO with non-obese is 16.55±8.09 µmol/L and obese is 21.00±6.27 µmol/L. 
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